Digital Looking beyond the scale: Why measures of physical activity ... GLP-1 receptor agonists like Ozempic and Wegovy are dramatically changing how healthcare professionals approach the treatment of obesity in patients.
Digital Balancing innovation and efficiency in clinical trials: Is t... Clinical trials face rising complexity, but simplifying processes and focusing on user experiences can enhance efficiency and patient outcomes
Digital JP Morgan Week 2025 – Phil Johnson Phil Johnson chat about why he joined Evidation and his excitement about the company’s mission.
Digital How do HCPs view the potential of AI in the pharmaceutical i... “AI has arrived,” British Prime Minister Keir Starmer declared in a recent speech.
Digital Simulated clinical trial populations and AI scalability AI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical.
Digital Key trends shaping pharmaceutical operations in 2025 2025 will be a challenging year for many sectors with multiple headwinds, and the pharmaceutical industry is no exception.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.